Predicting Progression of Developing Myeloma in a High Risk-Screened Population (PROMISE)
R
Rafat Abonour, MD
Primary Investigator
Recruiting
40-75 years
All
Phase
N/A
1 Location
Brief description of study
We will further study people who test positive for these early warning signs of multiple myeloma so that we can learn how to prevent them from developing into cancer.
Your participation may help researchers find new ways to prevent and treat blood cancer.
Detailed description of study
Please take our survey to see if you qualify: PROMISE Eligibility Questionnaire
This study aims to find new ways to prevent
and treat blood cancer.
For more information, please visit the PROMISE study
website: https://www.enroll.promisestudy.org/
Your participation may help prevent
multiple myeloma in future generations.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: healthy
-
Age: Between 40 Years - 75 Years
-
Gender: All
Inclusion criteria
- People who may have higher risks, but have not been diagnosed with multiple myeloma, another blood cancer, or related conditions
Updated on
01 Aug 2024.
Study ID: 18-370
Find a site
,
You have contacted , on
Your message has been sent to the study team at ,
A copy of the message has been sent to your email
What happens next?
- You can expect the study team to contact you via email or phone in the next few days.
- Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.
You are contacting
Primary Contact
